نتایج جستجو برای: gvhd

تعداد نتایج: 4940  

Journal: :The New England Journal of Medicine 2021

Dipeptidyl peptidase 4 (DPP-4; also known as CD26), a transmembrane receptor expressed on T cells, has costimulatory function in activating cells. In mouse model, down-regulation of CD26 prevented graft-versus-host disease (GVHD) but preserved graft-versus-tumor effects. Whether inhibition DPP-4 with sitagliptin may prevent acute GVHD after allogeneic stem-cell transplantation is not known.

Background:  Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) is used as treatment of choice for patients with acute myeloid leukemia (AML). We aimed to evaluate the prognostic factors in 2-year overall survival of patients with non-M3 AML who underwent allogenic HSCT. Methods: This is a Cross sectional retrospective study. Demographic data and study of variables such as age...

Journal: :Blood 2007
Yukimi Sakoda Daigo Hashimoto Shoji Asakura Kengo Takeuchi Mine Harada Mitsune Tanimoto Takanori Teshima

Chronic graft-versus-host disease (GVHD) is the most common cause of poor long-term outcomes after allogeneic bone marrow transplantation (BMT), but the pathophysiology of chronic GVHD still remains poorly understood. We tested the hypothesis that the impaired thymic negative selection of the recipients will permit the emergence of pathogenic T cells that cause chronic GVHD. Lethally irradiated...

Journal: :Blood 2012
Junya Kanda Masakatsu Hishizawa Atae Utsunomiya Shuichi Taniguchi Tetsuya Eto Yukiyoshi Moriuchi Ryuji Tanosaki Fumio Kawano Yasushi Miyazaki Masato Masuda Koji Nagafuji Masamichi Hara Minoko Takanashi Shunro Kai Yoshiko Atsuta Ritsuro Suzuki Takakazu Kawase Keitaro Matsuo Tokiko Nagamura-Inoue Shunichi Kato Hisashi Sakamaki Yasuo Morishima Jun Okamura Tatsuo Ichinohe Takashi Uchiyama

Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for adult T-cell leukemia (ATL), raising the question about the role of graft-versus-leukemia effect against ATL. In this study, we retrospectively analyzed the effects of acute and chronic graft-versus-host disease (GVHD) on overall survival, disease-associated mortality, and treatment-related mortality among 294 ATL...

Journal: :Blood 2014
Javier Bolaños-Meade Brent R Logan Amin M Alousi Joseph H Antin Kate Barowski Shelly L Carter Steven C Goldstein Elizabeth O Hexner Mary M Horowitz Stephanie J Lee John E Levine Margaret L MacMillan Paul J Martin Adam M Mendizabal Ryotaro Nakamura Marcelo C Pasquini Daniel J Weisdorf Peter Westervelt Vincent T Ho

Corticosteroids are the accepted primary therapy for acute graft-versus-host disease (GVHD), but durable responses are seen in only about half of the patients. Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0802, a phase 3 multicenter randomized double-blinded trial, was designed to test whether mycophenolate mofetil (MMF) plus corticosteroids was superior to corticosteroids alon...

2014
Julia Cromvik Marianne Johnsson Krista Vaht Jan-Erik Johansson Christine Wennerås

While increased numbers of eosinophils may be detected in patients with graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation, it is not known if eosinophils play a role in GVHD. The aims of this study were to determine: whether eosinophils are activated during GVHD; whether the patterns of activation are similar in acute and chronic GVHD; and the ways in which syst...

2014
Shigeo Fuji Markus Kapp Hermann Einsele

Graft-versus-host disease (GVHD) is still one of the major causes of morbidity and mortality in allogeneic hematopoietic stem cell transplantation (HSCT). In the pathogenesis of acute GVHD, it has been established that donor-derived T-cells activated in the recipient play a major role in GVHD in initiation and maintenance within an inflammatory cascade. To reduce the risk of GVHD, intensificati...

Journal: :The Journal of clinical investigation 1998
Y G Yang B R Dey J J Sergio D A Pearson M Sykes

We have demonstrated that a single injection of interleukin (IL)-12 on the day of bone marrow transplantation (BMT) inhibits acute graft-versus-host disease (GVHD) in mice. This effect of IL-12 can be diminished by anti-interferon (IFN)-gamma mAb. To determine the mechanism by which IFN-gamma affects IL-12-mediated GVHD protection, we have compared the effect of IL-12 on GVHD in C57BL/6 wild-ty...

2014
Ji-Min Ju Hakmo Lee Keunhee Oh Dong-Sup Lee Eun Young Choi

Graft-versus-host disease (GVHD) is a fatal complication that occurs after allogeneic hematopoietic stem cell transplantation. To understand the dynamics of CD4 and CD8 T cell production of IFN-γ and IL-17 during GVHD progression, we established a GVHD model by transplanting T cell-depleted bone marrow (TCD-BM) and purified T cells from B6 mice into irradiated BALB.B, creating an MHC-matched bu...

Journal: :Blood 2015
Joanna J Messmann Tanja Reisser Frank Leithäuser Manfred B Lutz Klaus-Michael Debatin Gudrun Strauss

Myeloid-derived suppressor cells (MDSCs) inhibit T-cell expansion and functions by versatile mechanisms such as nutrient depletion, nitrosylation, or apoptosis. Since graft-versus-host disease (GVHD) is characterized by the expansion of donor-derived T cells destroying recipient tissue, we analyzed whether MDSCs can be used for GVHD prevention in murine allogeneic bone marrow transplantation mo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید